Azura Ophthalmics

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

Amber Ophthalmics

The company develops biopharmaceutical therapies to treat rare anterior segment eye diseases such as persistent corneal epithelial defects for patients.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Eyevance Pharmaceuticals

This company develops and commercialises prescription ophthalmic products to treat ocular surface diseases for ophthalmologists, optometrists and their patients.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Aviceda

This biotechnology company develops nanoparticle glyco-therapeutics for patients with immune-mediated diseases, primarily targeting macular degeneration and other ophthalmic, neurological and inflammatory conditions.

VISUfarma

This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.